Funding news
Secretome Therapeutics logo

Secretome Therapeutics Raises $30.0M Series

Recently funded · $30.0M Series aHospitals and Health CareUSView source

Get the full Secretome Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Secretome Therapeutics, a biotech company developing a novel cell therapy approach for inflammatory diseases, has secured $30.0M in Series A funding. The round, led by RA Capital Management, provides substantial capital to advance its work in leveraging neonatal cardiac progenitor cells and their secretomes.

This investment underscores confidence in Secretome Therapeutics' mission to revolutionize how these conditions are treated. The fresh capital will support the company's ongoing efforts to bring its innovative therapies closer to patients.

Secretome Therapeutics, a Plano, TX-based clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC), has raised $30 million in a Series A funding round led by RA Capital Management. David Lubner will join Secretome’s Board of Directors.

The Series A funding will support operations and help advance Secretome Therapeutics’ pipeline, including STM-01, a therapy derived from neonatal cardiac progenitor cells that is being developed for Duchenne muscular dystrophy-related cardiomyopathy and other rare heart conditions linked to neuromuscular diseases. 🔗 Read full article link in comment #secretometherapeutics #biotech #startupnews

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Abstract logo

Abstract

United States

$59.0M
2
Pacifico Biolabs logo

Pacifico Biolabs

$7.6M
3
Solstice logo

Solstice

United States

$21.0M
4
Geordie AI logo

Geordie AI

United Kingdom

$30.0M
5
Lastwall logo

Lastwall

Canada

$11.5M